Falling behind giant migraine drug rivals, Alder ousts founder Randy Schatzman — could a buyout be next?
After 14 years at the helm of Alder BioPharmaceuticals $ALDR, company co-founder Randy Schatzman is out in what the company calls a “mutual decision …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
